Literature DB >> 23992479

Outgrowth of the bacterial airway microbiome after rhinovirus exacerbation of chronic obstructive pulmonary disease.

Philip L Molyneaux1, Patrick Mallia, Michael J Cox, Joseph Footitt, Saffron A G Willis-Owen, Daniel Homola, Maria-Belen Trujillo-Torralbo, Sarah Elkin, Onn Min Kon, William O C Cookson, Miriam F Moffatt, Sebastian L Johnston.   

Abstract

RATIONALE: Rhinovirus infection is followed by significantly increased frequencies of positive, potentially pathogenic sputum cultures in chronic obstructive pulmonary disease (COPD). However, it remains unclear whether these represent de novo infections or an increased load of organisms from the complex microbial communities (microbiome) in the lower airways.
OBJECTIVES: To investigate the effect of rhinovirus infection on the airway bacterial microbiome.
METHODS: Subjects with COPD (n = 14) and healthy control subjects with normal lung function (n = 17) were infected with rhinovirus. Induced sputum was collected at baseline before rhinovirus inoculation and again on Days 5, 15, and 42 after rhinovirus infection and DNA was extracted. The V3-V5 region of the bacterial 16S ribosomal RNA gene was amplified and pyrosequenced, resulting in 370,849 high-quality reads from 112 of the possible 124 time points.
MEASUREMENTS AND MAIN RESULTS: At 15 days after rhinovirus infection, there was a sixfold increase in 16S copy number (P = 0.007) and a 16% rise in numbers of proteobacterial sequences, most notably in potentially pathogenic Haemophilus influenzae (P = 2.7 × 10(-20)), from a preexisting community. These changes occurred only in the sputum microbiome of subjects with COPD and were still evident 42 days after infection. This was in contrast to the temporal stability demonstrated in the microbiome of healthy smokers and nonsmokers.
CONCLUSIONS: After rhinovirus infection, there is a rise in bacterial burden and a significant outgrowth of Haemophilus influenzae from the existing microbiota of subjects with COPD. This is not observed in healthy individuals. Our findings suggest that rhinovirus infection in COPD alters the respiratory microbiome and may precipitate secondary bacterial infections.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23992479      PMCID: PMC3863728          DOI: 10.1164/rccm.201302-0341OC

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  40 in total

1.  Chimeric 16S rRNA sequence formation and detection in Sanger and 454-pyrosequenced PCR amplicons.

Authors:  Brian J Haas; Dirk Gevers; Ashlee M Earl; Mike Feldgarden; Doyle V Ward; Georgia Giannoukos; Dawn Ciulla; Diana Tabbaa; Sarah K Highlander; Erica Sodergren; Barbara Methé; Todd Z DeSantis; Joseph F Petrosino; Rob Knight; Bruce W Birren
Journal:  Genome Res       Date:  2011-01-06       Impact factor: 9.043

2.  Lung-enriched organisms and aberrant bacterial and fungal respiratory microbiota after lung transplant.

Authors:  Emily S Charlson; Joshua M Diamond; Kyle Bittinger; Ayannah S Fitzgerald; Anjana Yadav; Andrew R Haas; Frederic D Bushman; Ronald G Collman
Journal:  Am J Respir Crit Care Med       Date:  2012-07-12       Impact factor: 21.405

3.  Microbiologic determinants of exacerbation in chronic obstructive pulmonary disease.

Authors:  Antoni Rosell; Eduard Monsó; Néstor Soler; Ferràn Torres; Joaquim Angrill; Gerdt Riise; Rafael Zalacaín; Josep Morera; Antoni Torres
Journal:  Arch Intern Med       Date:  2005-04-25

4.  Phylogenetic relationships of Thiomicrospira species and their identification in deep-sea hydrothermal vent samples by denaturing gradient gel electrophoresis of 16S rDNA fragments.

Authors:  G Muyzer; A Teske; C O Wirsen; H W Jannasch
Journal:  Arch Microbiol       Date:  1995-09       Impact factor: 2.552

5.  New strains of bacteria and exacerbations of chronic obstructive pulmonary disease.

Authors:  Sanjay Sethi; Nancy Evans; Brydon J B Grant; Timothy F Murphy
Journal:  N Engl J Med       Date:  2002-08-15       Impact factor: 91.245

6.  Analysis of the lung microbiome in the "healthy" smoker and in COPD.

Authors:  John R Erb-Downward; Deborah L Thompson; Meilan K Han; Christine M Freeman; Lisa McCloskey; Lindsay A Schmidt; Vincent B Young; Galen B Toews; Jeffrey L Curtis; Baskaran Sundaram; Fernando J Martinez; Gary B Huffnagle
Journal:  PLoS One       Date:  2011-02-22       Impact factor: 3.240

7.  UniFrac--an online tool for comparing microbial community diversity in a phylogenetic context.

Authors:  Catherine Lozupone; Micah Hamady; Rob Knight
Journal:  BMC Bioinformatics       Date:  2006-08-07       Impact factor: 3.169

8.  Disordered microbial communities in asthmatic airways.

Authors:  Markus Hilty; Conor Burke; Helder Pedro; Paul Cardenas; Andy Bush; Cara Bossley; Jane Davies; Aaron Ervine; Len Poulter; Lior Pachter; Miriam F Moffatt; William O C Cookson
Journal:  PLoS One       Date:  2010-01-05       Impact factor: 3.240

9.  Statistical methods for detecting differentially abundant features in clinical metagenomic samples.

Authors:  James Robert White; Niranjan Nagarajan; Mihai Pop
Journal:  PLoS Comput Biol       Date:  2009-04-10       Impact factor: 4.475

Review 10.  Chronic obstructive pulmonary disease: a growing but neglected global epidemic.

Authors:  Peter J Barnes
Journal:  PLoS Med       Date:  2007-05       Impact factor: 11.069

View more
  139 in total

Review 1.  The Microbiome and the Respiratory Tract.

Authors:  Robert P Dickson; John R Erb-Downward; Fernando J Martinez; Gary B Huffnagle
Journal:  Annu Rev Physiol       Date:  2015-11-02       Impact factor: 19.318

Review 2.  The microbiome and critical illness.

Authors:  Robert P Dickson
Journal:  Lancet Respir Med       Date:  2015-12-12       Impact factor: 30.700

Review 3.  Understanding the role of the microbiome in chronic obstructive pulmonary disease: principles, challenges, and future directions.

Authors:  Yvonne J Huang; John R Erb-Downward; Robert P Dickson; Jeffrey L Curtis; Gary B Huffnagle; MeiLan K Han
Journal:  Transl Res       Date:  2016-06-23       Impact factor: 7.012

Review 4.  The Lung Microbiome and Its Role in Pneumonia.

Authors:  Benjamin G Wu; Leopoldo N Segal
Journal:  Clin Chest Med       Date:  2018-12       Impact factor: 2.878

Review 5.  The role of the microbiome in exacerbations of chronic lung diseases.

Authors:  Robert P Dickson; Fernando J Martinez; Gary B Huffnagle
Journal:  Lancet       Date:  2014-08-23       Impact factor: 79.321

6.  Airway microbiome dynamics in exacerbations of chronic obstructive pulmonary disease.

Authors:  Yvonne J Huang; Sanjay Sethi; Timothy Murphy; Snehal Nariya; Homer A Boushey; Susan V Lynch
Journal:  J Clin Microbiol       Date:  2014-05-21       Impact factor: 5.948

Review 7.  The respiratory microbiome in idiopathic pulmonary fibrosis.

Authors:  Richard J Hewitt; Philip L Molyneaux
Journal:  Ann Transl Med       Date:  2017-06

Review 8.  Microbiome in chronic obstructive pulmonary disease.

Authors:  Eduard Monsó
Journal:  Ann Transl Med       Date:  2017-06

9.  The infant nose. Introducing the respiratory tract to the world.

Authors:  Joseph P Mizgerd
Journal:  Am J Respir Crit Care Med       Date:  2014-12-01       Impact factor: 21.405

Review 10.  The role of the local microbial ecosystem in respiratory health and disease.

Authors:  Wouter A A de Steenhuijsen Piters; Elisabeth A M Sanders; Debby Bogaert
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2015-08-19       Impact factor: 6.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.